Quality Management Considerations for Emerging Companies in the Pharmaceutical Industry

6 Pages

This insight brief addresses how emerging biopharma companies can build fit-for-purpose quality management systems (QMS) as products progress from R&D to clinical and commercial stages. It explains when GMP controls become critical, how to “right-size” QMS investments, and the importance of supplier qualification and quality agreements. The paper emphasizes early planning, gap assessments, and scalable quality frameworks to avoid delays, regulatory risk, and costly rework.

Join for free to read

Case Study IIoT in the pharmaceutical industry

White Paper THE EVOLUTION OF PHARMACEUTICAL MES

Case Study Zhongxi Sunve Automates and Enhances Pharmaceutical Quality…

Ebook Helping Pharmaceutical Companies Grow

More from IQVIA

Report Emerging Biopharma’s Contribution to Innovation

Report Valuing the Research-based Pharmaceutical

White Paper A New Margin Era for the Pharmaceutical

White Paper Delivering Transformative Impact in the Southeast Asia…

Ebook

Quality Management Considerations for Emerging Companies in the Pharmaceutical Industry

Quality Management Considerations for Emerging Companies in the Pharmaceutical Industry

You Might Also Like

More from IQVIA